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Abstract A general radioprotective effect by fibroblast
growth factor (FGF) has been extensively described since
the early 1990s; however, the molecular mechanisms in-
volved remain largely unknown. Radiation-induced DNA
double-strand breaks (DSBs) lead to a complex set of
responses in eukaryotic cells. One of the earliest conse-
quences is phosphorylation of histone H2AX to form
nuclear foci of the phosphorylated form of H2AX
(cH2AX) in the chromatin adjacent to sites of DSBs and
to initiate the recruitment of DNA-repair molecules. Upon
a DSB event, a rapid signaling network is activated to
coordinate DNA repair with the induction of cell-cycle
checkpoints. To date, three kinases (ATM, ATR, and
DNA-PK) have been shown to phosphorylate histone
H2AX in response to irradiation. Here, we report a ki-
nome-targeted small interfering RNA (siRNA) screen to
characterize human kinases involved in H2AX phospho-
rylation. By analyzing cH2AX foci at a single-nucleus
level, we identified 46 kinases involved either directly or
indirectly in H2AX phosphorylation in response to irra-
diation in human keratinocytes. Furthermore, we
demonstrate that in response to irradiation, the FGFR4
signaling cascade promotes JNK1 activation and direct
H2AX phosphorylation leading, in turn, to more efficient
DNA repair. This can explain, at least partially, the ra-
dioprotective effect of FGF.
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Introduction
As early as 1991, an autocrine effect of fibroblast growth
factor (FGF) in the repair of radiation damage was reported
[1], and soon after the same group showed that FGFs
protected endothelial cells against radiation-induced pro-
grammed cell death [2, 3]. Since then, it has been
confirmed by different groups that FGF inhibits radiation-
induced apoptosis in HUVEC [4, 5], hair follicle [6], and
rat small intestine [7] cells. Thereafter, numerous papers
have reported a general radioprotective effect of FGF [8–
10]. However, to date, there is no real characterization of
the molecular mechanisms involved in this process.
Phosphorylation of histone H2AX is one of the earliest
responses to radiation-induced DNA damage [11]. There is
a linear relationship between double-strand breaks (DSBs)
as directly estimated from the number of cH2AX foci and
the quantity of energy deposition within cells from 1 to
100 Gy [12]. Monitoring the formation of cH2AX foci is
the most sensitive method of detecting DSBs and, as a
consequence, is a very interesting approach for evaluating
human exposure to ionizing radiation [13]. Because most
anti-cancer drugs also induce DSBs, monitoring the
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formation of cH2AX foci has the potential for evaluating
cancer progression and therapeutic efficacy [14–17].
Members of the PI3 kinase family, including ataxia te-
langiectasia mutated (ATM), AT and Rad3-related protein
(ATR), and DNA-dependent protein kinase (DNA-PK), are
the enzymes responsible for H2AX phosphorylation at a
serine located four residues from the carboxyl terminus
[18–20]. However, cH2AX-positive cells are also detected
in the skin and kidneys of mice lacking either ATM or
DNA-PK, suggesting that these kinases are not the only
ones to phosphorylate H2AX in vivo [21, 22]. Thus, H2AX
is a target of JNK signaling and appears to trigger apoptotic
DNA fragmentation [23]. Similarly, serum starvation in-
duces p38-dependent H2AX phosphorylation to induce
apoptosis [24]. Together, these results suggest that different
signaling cascades could be involved in the phosphoryla-
tion of H2AX. Therefore, we hypothesized a possible link
between the radioprotective effect of FGF and the FGF
receptor signaling pathway with the phosphorylation of
H2AX. To address this issue, we exhaustively character-
ized all human kinases involved in the phosphorylation of
H2AX.
Several studies have highlighted the power of large-s-
cale RNA interference (RNAi) screening approaches to
characterize the relevance of specific genes in signaling
cascades. Novel loci required for JAK/STAT signaling
have been identified by genome-wide RNAi in Drosophila
cells [25]. A global view of receptor tyrosine kinase (TRK)
signaling through the extracellular signal-regulated kinase
(ERK) pathway was obtained thanks to an RNAi-based
genome-wide screen in Drosophila cells [26]. Similarly, all
human kinases and phosphatases involved in apoptosis in
humans have been characterized through a systematic
RNAi screen [27]. Signaling networks controlling the
Golgi apparatus in human cells have also been character-
ized through RNAi screening [28]. Signaling cascades for
DNA damage-associated G1 checkpoint responses were
also identified [29]. Furthermore, these RNAi-based
screens may aid in the identification of low-frequency ge-
netic changes that can contribute to oncogenesis. Indeed,
some authors have estimated that individual mutations in as
many as 20 % of all human kinases can play an active role
in tumorigenesis [30]. Therefore, by mimicking loss-of-
function mutations, kinome-targeted RNAi-based screens
may help to identify low-frequency oncogenic genetic
changes in the human kinome.
Here, we used siRNA microarrays [31, 32] to perform a
kinome-targeted RNAi-based screen to exhaustively char-
acterize all human kinases involved in the phosphorylation
of H2AX in response to irradiation in skin cells. We
monitored, at the single-cell level, the effect of siRNA-
dependent specific inhibition of approximately 650 human
kinases on H2AX phosphorylation in response to
irradiation in human skin cells. We have identified 46 ki-
nases that directly or indirectly participate in the formation
of cH2AX foci. Strikingly, several of these kinases belong
to the FGF receptor signaling pathway.
Materials and methods
siRNA library
The Human Kinase siRNA set contained 1292 siRNAs
targeting 646 kinases and kinase-associated genes (Qiagen,
Valencia, CA, USA, Cat. no.: 1027091). This siRNA li-
brary set was designed using an informatics algorithm
against all known human kinases, which ensures highly
efficient knockdown in cells. The library was synthesized
with two siRNA duplexes for each gene. As a negative
control, an siRNA without homology to any known
mammalian gene was used (AllStars negative control,
Qiagen, Valencia, CA, USA). As a positive control, an




The general procedure for cell microarray manufacturing
was based on Ziauddin and Sabatini’s work [33]. As de-
scribed in Fig. 1a, optimization was necessary to improve
siRNA transfection into the cell line used here and to
achieve good reproducibility of siRNA transfection. The
siRNA set was provided in seventeen 96-well plates. The
siRNA-polymer transfection solution was prepared in
seventeen 96-well plates used for microarray printing (or
seventeen batches of slides). In each well, 0.5 ll of siRNA
duplexes (20 lM) of each target was mixed successively
with 10 ll of phosphate-buffered saline and 2 ll of a
1.5 M sucrose solution. This mixture was supplemented
with 2 ll of transfection reagent (INTERFERin, Polyplus-
transfection, Illkirch, France). After a 10-min incubation at
room temperature, 3 ll of a 1 % gelatin solution (Sigma
G-1393 diluted in deionized water) and 3 ll of MatrigelTM
(BD Biosciences, San Jose, CA, USA) were added in
succession. The siRNA-polymer solution was arrayed in
triplicate onto Superfrost Plus slides (Menzel-Gla¨ser,
Braunschweig, Germany) using a Microgrid II Biorobotics
(Cambridge, UK) microarrayer at room temperature with
six Biorobotics pins. The spots were 500 lm in diameter,
and the dot spacing was 1100 lm. The siRNA microarray
was composed of six blocks of 8 9 8 spots. Each block
contained negative and positive controls (Figs. 1b, 2a).
With this condition, 384 features per microarray were
printed. Each siRNA-targeted kinase was arrayed in
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triplicate. However, an occasional spot may be missing on
a microarray due to dysfunction of a printing pin. We
manufactured a total of five siRNA microarrays for the
study, which were stored at room temperature in a dry
atmosphere until they were further processed.
Cell culture and reverse transfection for the arrays
The human keratinocyte cell line HaCaT was generously
provided by N. E. Fusenig (German Cancer Research
Center, Heidelberg, Germany). HaCaT cells were grown at
37 C in a 5 % CO2 humidified atmosphere in calcium
chloride-free Dulbecco’s modified Eagle’s medium con-
taining 4.5 g/l glucose supplemented with 10 % (v/v) fetal
calf serum, 100,000 U/l penicillin, 50 mg/l streptomycin,
and 200 mM L-glutamine. The cells were seeded at
50,000 cells/cm2 onto RNAi microarrays in 100-mm Petri
dishes. The cells were reverse-transfected by growing them
on the siRNA spot without further manipulation. Twenty-
























Fig. 1 siRNA microarray.
a HaCaT cells were grown on
slides spotted with an siRNA
library targeting the human
kinome. Each spot on the
microarray contained one
specific siRNA. Forty-eight
hours after transfection, the
cells were irradiated at 2 Gy.
Thirty minutes after irradiation,
the cells were fixed and stained
with DAPI and a cH2AX
antibody. b Nuclei were stained
in blue by DAPI and cH2AX
was stained in red (Cy3-labeled
specific antibodies). Images
were automatically captured
with an IMSTAR platform
(Paris, France). cH2AX-specific
fluorescence intensity was
measured for each nucleus
(DAPI) and quantified
automatically
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Fig. 2 Data analysis. a Schematic representation of the siRNA
microarray. Each spot on the microarray is schematized by a colored
square. The color scale on the left reflects the number of cells on each
spot. b Individual histograms for each of the 64 spots in block 2 of the
microarray. Higher resolution areas of the histograms correspond to
the negative control siRNA (c), ATM-targeted siRNA as the positive
control (d) and JAK1-targeted siRNA (e). f Density curves generated
from the histograms presented in c–e
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and replaced by 10 ml of preheated medium. Cells reached
90 % confluence 48 h after transfection. The entire ex-
periment was repeated on five microarrays.
Exposure of cell cultures to ionizing radiation
Two days after reverse or standard transfection, the HaCaT
cells were irradiated with 2 Gy from a 137Cs source (IBL
637, CisBio International, Saclay, France) at a dose rate of
1.724 Gy/min or the Ane´mone/Bio irradiator (60Co, 2 Gy/
min) in the ARC-Nucle´art facility at CEA-Grenoble. After
irradiation, the cultures were returned to the incubator.
Thirty minutes later, the reverse-transfected cells were
fixed in ice-cold methanol for 1 min and then washed three
times with phosphate-buffered saline and stored at 4 C.
Standard transfected cells were lysed after 30 min of in-
cubation using RIPA buffer (50 mM Tris–HCl, pH 7.4,
1 % Nonidet P-40, 0.25 % sodium deoxycholate, 150 mM
NaCl, 1 mM EDTA, 1 mM Na3VO4, and 1 mM NaF)
supplemented with 19 protease inhibitors (complete
EDTA-free, Roche, Indianapolis, IN) to extract total
proteins.
siRNA microarray image acquisition and analysis2
Forty-eight hours after cell transfection, siRNA microar-
rays were irradiated at 2 Gy, and cells were fixed 30 min
later. cH2AX foci formation was monitored by Cy3-la-
beled immunofluorescence, and nuclei were stained with
DAPI. To measure cH2AX fluorescence in the nuclei of
transfected cells, images were acquired with a Pathfinder
OSA instrument developed by IMSTAR (Paris, France)
and an automated optical scanning system equipped with a
high resolution (1300 9 1000 pixels) CCD camera with a
dynamic range of 12 bits or 4096 levels of intensity per
pixel, coupled to a Nikon fluorescence microscope (Nikon
Corporation, Tokyo, Japan). The significance of the read-
out and metrics used was first verified in human HaCaT
cells irradiated at 2 Gy and compared to non-irradiated
cells (Fig. S1A). Because of the nucleus-to-nucleus vari-
ability of cH2AX-specific fluorescence, we compare
histograms of cH2AX-specific fluorescence at the single-
nucleus level from the entire cell population in triplicates
rather than the averaged cH2AX signal (Fig S1B). The
Pathfinder OSA instrument was programmed to visit each
transfected cell spot on the siRNA microarray, perform an
autofocus with DAPI, and automatically and uniformly
acquire Cy3 images at a magnification of 409 with a final
resolution of 0.34 lm/pixel. Two-channel images (DAPI
and Cy3) were stored as frames of 16-bit Tiff images in a
built-in image database (Fig. 1b). Each image contained
approximately 60 HaCaT cells. Because each siRNA tar-
geting a given kinase was spotted in triplicate on the
microarrays, approximately 180 cells were analyzed per
siRNA (Fig. 2a), and two different siRNAs were used per
kinase. The nuclei of all of the cells in a spot were detected
and quantified in the DAPI channel, and the nuclear area
was automatically segmented and contoured. Using the
Cy3 channel, the total fluorescence intensity of cH2AX
staining in each nucleus was calculated. To compare the
putative effect of a given siRNA on H2AX phosphoryla-
tion, we built fluorescence mean intensity histograms
(Fig. 2b). Histograms of cH2AX-specific fluorescence at
the single-nucleus level were obtained from the entire cell
population in triplicate (Fig. 2c–e). Density curves were
then automatically generated from the histograms (Fig. 2f).
The density curve obtained for each siRNA was compared
to the negative control density curve of cells transfected
with an siRNA having no known target in the human
genome and to the positive control density curve of an
siRNA specifically targeting ATM, a kinase known to
phosphorylate H2AX (Fig. 2f). Only when both controls
behaved as expected in one block on the microarray were
the siRNAs spotted in that block further analyzed. The
density curve shift for each siRNA was then compared to
the negative control density curve, and the significance of
the shift was then further assessed by Mann–Whitney
U test, which is a statistical test of the null hypothesis that
two populations are the same against an alternative hy-
pothesis. The siRNAs that showed a significant shift
(p value \1 %) of their density curve were considered
potential hits. As demonstrated in Table 1, to further in-
crease the statistical robustness of the screening procedure,
we performed five independent biological replicates (5
siRNA microarrays). Therefore, all together we had up to
15 replicates for each siRNA (sometimes fewer when spots
were missing due to inefficient printing on the siRNA
microarrays or not enough cells were on a spot). A kinase
was considered a hit when at least one of the two siRNAs
targeting that kinase passed the statistical test at least 3
times (Table 1).
Primary keratinocytes
Human keratinocytes were isolated from neonatal foreskin
obtained from routine circumcisions. The biopsies were
preserved in DMEM-PS (medium containing penicillin–
streptomycin) and kept at 4 C. Afterward, keratinocyte
cell suspensions were prepared using thermolysin in com-
bination with trypsin–EDTA. Biopsies were kept in PBS
containing 0.5 mg/ml thermolysin at 4 C for 16–20 h.
Subsequently, the dermis and epidermis were separated
with a pair of forceps, and the epidermis was incubated for
60 min at room temperature in PBS containing 0.125 %
trypsin and 0.05 % EDTA under magnetic stirring. Then,
10 % FCS was added, and the cells were resuspended and
FGF signaling linked to H2AX phosphorylation… 3563
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Table 1 List of positive kinases identified by the genome-wide kinome-targeted screen
KINASE Gene ID KINBASE family HIT seq1 HIT seq2 Réf. séq1 Réf. séq2
ADRBK1 156 AGC:GRK:BARK 4(5) 0(5) HUQKIN:002F10 HUQKIN:002E10
AKAP13 11214 noFamily 4(5) 1(5) HUQKIN:011B5 HUQKIN:011A5
AKAP6 9472 noFamily 3(4) 0(4) HUQKIN:007B7 HUQKIN:007A7
AURKC 6795 Other:Aur 3(4) 2(4) HUQKIN:005D10 HUQKIN:005C10
BMPR1A 657 TKL:STKR:Type1 4(4) 4(4) HUQKIN:007B8 HUQKIN:007A8
CAMK2D 817 CAMK:CAMK2 4(5) 1(5) HUQKIN:002F4 HUQKIN:002E4
CAMK4 814 CAMK:CAMK1 2(4) 3(4) HUQKIN:003B3 HUQKIN:003A3
CDKL5 6792 CMGC:CDKL 3(4) 3(4) HUQKIN:005B10 HUQKIN:005A10
CDKN1B 1027 noFamily 2(4) 3(4) HUQKIN:007H4 HUQKIN:007G4
CHEK2 11200 CAMK:RAD53 4(5) 3(5) HUQKIN:011F8 HUQKIN:011E8
CSK 1445 TK:Csk 3(4) 3(4) HUQKIN:007H8 HUQKIN:007G8
DTYMK 1841 noFamily 4(5) 2(5) HUQKIN:011D10 HUQKIN:011C10
EPHB3 2049 TK:Eph 3(4) 2(4) HUQKIN:007H10 HUQKIN:007G10
ERBB3 2065 TK:EGFR 3(4) 0(4) HUQKIN:003D7 HUQKIN:003C7
FASTK 10922 Atypical:FAST 4(5) 2(5) HUQKIN:011F4 HUQKIN:011E4
FES 2242 TK:Fer 3(4) 1(4) HUQKIN:003F7 HUQKIN:003E7
FGFR4 2264 TK:FGFR 3(4) 1(4) HUQKIN:003H7 HUQKIN:003G7
JAK1 3716 TK:JakA 4(4) 2(4) HUQKIN:003D10 HUQKIN:003C10
KDR 3791 TK:VEGFR 3(4) 1(4) HUQKIN:003F10 HUQKIN:003E10
LIMK1 3984 TKL:LISK:LIMK 4(4) 3(4) HUQKIN:003H10 HUQKIN:003G10
LYN 4067 TK:Src:SrcB 0(4) 3(4) HUQKIN:003D11 HUQKIN:003C11
MAP2K4 6416 STE:STE7:MEK4 3(4) 2(4) HUQKIN:005D9 HUQKIN:005C9
MAP3K14 9020 STE:STE-Unique 3(4) 2(4) HUQKIN:007B4 HUQKIN:007A4
MAPK1 5594 CMGC:MAPK:ERK1 3(4) 3(4) HUQKIN:005F3 HUQKIN:005E3
MAPK8/JNK1 5599 CMGC:MAPK:JNK 1(4) 4(4) HUQKIN:005H4 HUQKIN:005G4
MARK3 4140 AMK:CAMKL:MAR 1(5) 5(5) HUQKIN:004D2 HUQKIN:004C2
PAK1 5058 STE:STE20:PAKA 2(5) 5(5) HUQKIN:004B5 HUQKIN:004A5
PHKA1 5255 noFamily 4(5) 5(5) HUQKIN:004B8 HUQKIN:004A8
PIK3C3 5289 noFamily 5(5) 3(5) HUQKIN:004H8 HUQKIN:004G8
PIK3CD 5293 noFamily 3(5) 4(5) HUQKIN:008B10 HUQKIN:008A10
PIK3R2 5296 noFamily 2(5) 4(5) HUQKIN:008D10 HUQKIN:008C10
PIP5K2A 5305 noFamily 4(5) 3(5) HUQKIN:008F10 HUQKIN:008E10
PRKAR2A 5576 noFamily 3(4) 1(4) HUQKIN:007H5 HUQKIN:007G5
PRKR 5610 Other:PEK:PKR 3(4) 3(4) HUQKIN:005B7 HUQKIN:005A7
PRKY 5616 AGC:PKA 3(4) 2(4) HUQKIN:005D7 HUQKIN:005C7
PSKH1 5681 CAMK:PSK 4(5) 3(5) HUQKIN:011D5 HUQKIN:011C5
PTK9 5756 noFamily 2(4) 3(4) HUQKIN:005F7 HUQKIN:005E7
PTK9L 11344 noFamily 4(5) 2(5) HUQKIN:011B10 HUQKIN:011A10
RAF1 5894 TKL:RAF:RAF 3(4) 3(4) HUQKIN:005H7 HUQKIN:005G7
RPS6KB1 6198 AGC:RSK:p70 3(4) 3(4) HUQKIN:005F10 HUQKIN:005E10
SKP1A 6500 noFamily 3(5) 4(5) HUQKIN:011B7 HUQKIN:011A7
SRPK1 6732 CMGC:SRPK 2(4) 3(4) HUQKIN:005F9 HUQKIN:005E9
STK22C 81629 CAMK:TSSK 1(4) 3(4) HUQKIN:015D11 HUQKIN:015C11
STK29 9024 CAMK:CAMKL:BRS 3(4) 1(4) HUQKIN:007D4 HUQKIN:007C4
SYK 6850 TK:Syk 4(4) 3(4) HUQKIN:005H10 HUQKIN:005G10
TLK1 9874 Other:TLK 4(5) 1(5) HUQKIN:011F10 HUQKIN:011E10
Ref. seq 1 and Ref. seq 2 correspond to Qiagen references (Qiagen, Valencia, CA, USA, Cat. No. 1027091) of the two siRNAs targeting each
specific kinase. HIT seq 1 and HIT seq 2 correspond to the number of independent biological replicates performed with each siRNA (number
between brackets). Five siRNA microarrays were used; however, an occasional spot may have been missed from the printing process or
eliminated when there were too few cells on the spot. Thus, the number of repeats (between brackets) could be\5. The other number indicated
how many times the siRNA being analyzed successfully passed the statistical test at a p value of 1 % (see ‘‘Materials and methods’’). The table
lists the 46 kinases for which at least one of the two siRNAs passed the test at least 3 times. Gray lines in the table correspond to kinases that were
randomly chosen to be further validated in the study. Kinases already known to phosphorylate H2AX are indicated in bold. An siRNA targeting
ATM was used as a positive control, and siRNA AllStar was used as a negative control
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filtered with a 70-ml cell strainer (BD Biosciences, San
Jose, CA, USA) to remove the remaining aggregates prior
to counting.
Standard transfection
The HaCaT cells (3 9 105) were seeded in 5 ml of the
medium described above in 25 cm2 plastic flasks.
Twenty-four hours later, 6 ll of the 20 lM siRNA du-
plex and 20 ll of INTERFERin (Polyplus, Illkirch,
France) were diluted in 500 ll of DMEM without fetal
calf serum. Ten minutes later, the mix was added to the
cells with 4 ml of fresh medium for transcription. The
flasks were placed in an incubator at 37 C and 5 %
CO2 for 48 h. HaCaT cells were also co-transfected with
either pCMV6-XL5/FGFR4 plasmid or pCMV6-XL5/
Mock plasmid (Origene, MD, USA) along with an
siRNA control (siCTL) or an siRNA targeting ATM
(siATM). Transfection was carried out using jetPRIME
transfection reagent (Polyplus transfection, Illkirch,
France) according to the manufacturer’s instructions.
Briefly, cells were seeded (3 9 105 cells) into 25 cm2
flasks. Four micrograms of DNA and 50 pmol of siRNA
duplex were diluted in 200 ll of jetPRIME buffer, and
then 8 ll of jetPRIME reagent was added to the
mixture. The transfection mixture was added to the cells
after 15 min incubation at room temperature, and the
medium was changed after 24 h. Finally, cells were
assayed at 48 h post-transfection for the appropriate
activity. The same protocol was used to transfect human
ATM-deficient fibroblasts with either pCMV6-XL5/
FGFR4 or pCMV6-XL5/Mock plasmids (4 lg of DNA).
The culture medium was changed after 4 h of
transfection.
Primary antibodies and chemical inhibitors
The following antibodies were used in this study: anti-
histone H2AX (07-627; dilution 1:2000) and anti-pSer139-
H2AX (05-636; dilution 1:2000) (Upstate, Billerica, MA,
USA); anti-JAK1 (3332, dilution 1:1000) and anti-JNK1
(3708; dilution 1:1000) (Cell Signaling Technology, Dan-
vers, MA, USA); anti-FGFR4 (sc-124; dilution 1:200),
anti-pThr183/Tyr185-JNK (sc-6254; dilution 1:200), and
anti-ATM (sc-135663, dilution 1:200) (Santa Cruz
Biotechnology, Santa Cruz, CA, USA); anti-MARK3
(1952-1; dilution 1:2000) and anti-RAF1 (1560-1; dilution
1:500) (Epitomics, CA, USA) and anti-b-actin (A3854;
dilution 1:5000) (Sigma-Aldrich); anti-CDKN1B
(AHZ0452, Invitrogen; dilution 1:200); PHKA1
(H00005255-A01, Abnova, Taiwan; dilution 1:500); and
anti-PIK3CD (AP8020a, Abgent, CA, USA; dilution
1:500). To inhibit the JNK1 and ERK pathways, specific
inhibitors from Calbiochem (Billerica, MA, USA) were
used (JNK inhibitor 420119, JNK1 inhibitor negative
control 420123, ERK inhibitor 328007 and ERK inhibitor
negative control 328008). Stock solutions were prepared at
20 mM in DMSO, and the cells were treated with a final
concentration of 25 lM of inhibitor for 2 h before irra-
diation. PD173074 (FGFR1 and FGFR3 inhibitor) and
SU5402 (FGFR inhibitor) were purchased from Tocris and
Calbiochem, respectively, and both inhibitors were used at
a final concentration of 10 lM.
Immunofluorescence
The cells were incubated with a mouse monoclonal anti-
body against cH2AX, diluted 1:2000 in phosphate-buffered
saline supplemented with 10 % goat serum for 1 h at room
temperature in a humidified chamber. Excess antibody was
removed by washing the slides with phosphate-buffered
saline three times. Incubation with Cy3-conjugated goat
anti-mouse IgG (Jackson Immunoresearch Laboratories)
was performed at 1:800 in the dark at room temperature for
30 min. After several washes, the slides were mounted in
Vectashield mounting medium containing DAPI (Vector
Laboratories, Burlingame, CA, USA).
Colony-forming efficiency and colony
characterization
For the analysis of colony-forming efficiency (CFE),
HaCaT cells were transfected for 48 h, plated after irra-
diation at 2, 4, and 6 Gy at 10 cells/cm2 and grown for
14 days. HaCaT cells were stained and fixed with 1 %
crystal violet in methanol, and the number of colonies
containing more than 50 cells was counted by microscopy.
JNK interaction
Interactions between JNK1 and H2AX were observed us-
ing a SAPK/JNK assay kit (9810, Cell Signaling
Technology, Danvers, MA, USA). Briefly, HaCaT cells
(control or 2 Gy irradiation) were harvested 30 min, 1, 2,
or 4 h after irradiation, lysed in 1 ml of 20 mM Tris–HCl
(pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 %
Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM b-
glycerophosphate, 1 mM Na3VO4, 1 lg/ml leupeptin, and
1 mM PMSF), and sonicated. The lysates were cleared by
centrifugation (4 C, 13,000 rpm, 10 min) and then incu-
bated with GST-c Jun (1-89) beads overnight at 4 C on a
rocker. The next day, the beads were washed twice in lysis
buffer, twice in kinase buffer (25 mM Tris–HCl pH 7.5,
5 mM b-glycerophosphate, 2 mM DTT, 0.1 mM Na3VO4,
and 10 mM MgCl2), and resuspended in kinase buffer
containing 200 lM ATP. After a 30 min incubation at
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30 C, the kinase reaction was stopped with Laemmli
sample buffer and analyzed by Western blotting with
specific antibodies.
Lysing protocol and immunoblotting
Total cell extracts were prepared by lysing the cells on ice
for 20 min in radioimmunoprecipitation assay (RIPA)
buffer (50 mM Tris–HCl, pH 7.4, 1 % Nonidet P-40,
0.25 % sodium deoxycholate, 150 mM NaCl, 1 mM
EDTA, 1 mM Na3VO4, and 1 mM NaF) supplemented
with 19 protease inhibitors (complete EDTA-free, Roche,
Indianapolis, IN). The lysates were subjected to four pulses
of sonication to shear the DNA and centrifuged at
14,000 rpm for 10 min. The supernatants containing total
proteins were then analyzed by Western blotting as de-
scribed below. The samples were boiled for 5 min in 0.2 %
v/v of loading buffer (Lane Marker Reducing Sample
Buffer, 39000, Pierce), and equal amounts of total protein
were analyzed on a 4–12 % gradient gel (NuPAGE 4–12 %
Bis–Tris gel; Invitrogen). After electrophoresis, the pro-
teins were transferred onto a nitrocellulose membrane and
blocked for 1 h at room temperature in Tris-buffered saline
with Tween 20 (TBST) containing 5 % nonfat dry milk.
The blots were then incubated with primary antibody. After
several washes in TBST, the membranes were incubated in
TBST containing 5 % nonfat dry milk and a 1:5000 dilu-
tion of horseradish peroxidase-linked goat anti-rabbit or
anti-mouse antibody (Upstate, Billerica, MA, USA) for 1 h
at room temperature. Specific bands were visualized by




We used siRNA microarrays to enable massively parallel
reverse transfections of siRNAs into human skin cells be-
cause they are the first cells to be exposed to radiation
(Fig. 1a). Using this technology, we performed a kinome-
targeted siRNA-mediated loss-of-function screen to iden-
tify all human kinases involved in the phosphorylation of
histone H2AX and/or the formation of cH2AX foci upon
irradiation in the HaCaT cell line. We transfected 1292
siRNAs targeting 646 human kinases (two siRNAs/kinase)
with an average of 70 % transfection efficacy. Forty-eight
hours after transfection, the arrays were irradiated at 2 Gy,
and cells were fixed 30 min later. The cells were labeled
with two different fluorochromes, and the images were
captured and processed with a dedicated motorized mi-
croscope. DAPI-stained nuclei and cH2AX-specific
fluorescence were automatically quantified at the single-
nucleus level using specifically designed algorithms
(Fig. 1b, Fig. S1). This analysis of the signal at the single-
nucleus level was essential for determining cell-to-cell
variability in the cH2AX-specific signal within and be-
tween micropatterns on the siRNA microarrays, as
reflected in Fig. S1. Histograms of cH2AX-specific
fluorescence were averaged for each replicate, and the
corresponding density curves were generated automatically
(Fig. 2). The density curve obtained for each siRNA was
compared to the control density curve obtained by cells
transfected with an siRNA having no known target in the
human genome (Fig. 2f). A specific siRNA targeting ATM,
which is a kinase known to phosphorylate H2AX, was used
as a positive control and exhibited a significant shift of the
histogram toward a lower fluorescence intensity (Fig. 2b–
e). For each siRNA, the shift was compared to positive and
negative controls, and its significance was assessed by the
Mann–Whitney test (Fig. 2f). At a p value of 1 %, forty-six
kinases were found to have a direct or indirect effect on
H2AX phosphorylation (Table 1). Among those kinases,
most known kinase families were represented, but the ty-
rosine kinase family was the most prevalent (Table 2).
Validation of the putative kinases
Eight kinases (in gray in Table 1) were randomly selected
from the target list for further validation by Western blot-
ting to confirm knockdown of the targeted kinase as well as
inhibition of H2AX phosphorylation. Forward transfection
of siRNA into HaCaT cells was associated with siRNA-



















Kinases targeted by the Qiagen
siRNA collection
646 82 38 58 59 39 59 12 23 55 221
Hits alpha 1 % 46 9 3 3 7 3 4 0 1 3 13
Hits alpha 5 % 66 12 3 4 9 6 6 2 1 4 19
Kinase families are the following: TK tyrosine kinase, TKL tyrosine kinase like, AGC protein kinase C family, CAMK calcium/calmodulin-
dependent protein kinases, STE mitogen-activated protein kinase [MAPK] family, and CMGC cyclin-dependent protein kinases
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dependent silencing of all eight kinases. RAF1-targeted
siRNA was the only transfected siRNA not to efficiently
reduce the level of cH2AX; therefore, one can estimate that
7/8 (88 %) of the kinases tested were experimentally
validated (Fig. 3), suggesting that among the 46 targets
selected in the screen, nearly 40 of the kinases are likely to
be involved, either directly or indirectly, in the phospho-
rylation of H2AX and/or in the formation of cH2AX foci.
None of the kinases but JNK1 have been reported before as
having a role in the phosphorylation of histone H2AX.
These results suggest that the phosphorylation of histone
H2AX in response to DSBs involves many molecules in-
cluding several kinases, such as FGFR4 and JAK1, which
are either membrane bound or associated. The participation
of JNK1 and FGFR4 in the irradiation-dependent phos-
phorylation of H2AX was also confirmed in human
primary keratinocytes obtained from healthy donors
(Fig. 3b). Finally, to confirm the participation of numerous
kinases in H2AX phosphorylation, we analyzed the syn-
ergistic effect of kinase knockdown on the cytotoxic
response to irradiation, evaluated by colony-forming
efficiency. After irradiation at 6 Gy, the extinction of three
kinases, ATM, FGFR4, and JNK simultaneously, was more
toxic than the ablation of any kinase individually (Fig. 3c).
FGF signaling participates in H2AX
phosphorylation
Using the knowledge-based software Ingenuity, we iden-
tified the most prominent signaling pathways among our
list of kinase ‘‘hits.’’ Interestingly, although we screened
human HaCaT keratinocytes cells, B cell receptor (BCR)
signaling was the first pathway extracted from the IPA
database (p value = 10-17) (Fig. S2). As H2AX is required
for efficient immunoglobulin class switching in lympho-
cyte B [34, 35], this result was not unexpected and
indicated that kinases belonging to the BCR signaling
pathways in B cells also participate in H2AX phosphory-
lation in cells lacking B cell receptors, such as human
keratinocytes.
Several other pathways were also identified by the IPA



















































































Fig. 3 Validation of the screening results by Western blotting.
a Eight kinases selected in the screen were randomly chosen for
further validation. Seven of them exhibited reduced expression at the
protein level upon siRNA-mediated knockdown and reduced phos-
phorylation of H2AX in HaCaT cells after irradiation at 2 Gy.
b Knockdown of JNK1 and FGFR4 reduced the phosphorylation of
H2AX in primary keratinocytes after irradiation at 2 Gy. c Clonogenic
assay on HaCaT cells irradiated at 2, 4, and 6 Gy and previously
transfected with siCTL, siATM, siJNK1, siFGFR4 or a combination
of the last three siRNAs (siCOCK for cocktail). Error bars represent
standard deviation
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Fig. 4 Role of FGF signaling in H2AX phosphorylation. a Schematic
representation of FGF signaling. Kinases selected in the screen are in
red. Red-framed kinases are validated by Western blotting; the green-
framed kinase is the only protein not validated by Western blotting.
b Inhibition of FGF signaling by specific inhibitors PD173074 and
SU5402. Cells were treated for 4 h with 10 lM PD173074, SU5402,
or DMSO (mock) with and without irradiation at 2 Gy for 30 min.
c Similar to b using GAPDH as the loading control. d Similar to b but
with histones used as the loading control; ATM inhibitor was used at
10 lM as in the control. e Time-course inhibition of FGF signaling by
the specific inhibitor SU5402. Cells were treated for 1, 3, or 6 h with
10 lM SU5402 or DMSO (mock) with and without irradiation at
2 Gy for 30 min
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S3) and FGF signaling (p value = 10-11) (Fig. 4a). Within
the FGF signaling cascade, four kinases (FGFR4, PI3K,
ERK, and JNK1) were selected in the screening process,
and three were further validated. To confirm the role of
FGFR4 in H2AX phosphorylation in response to DSB and
to eliminate potential off-target effects, we inhibited FGF
signaling with two different chemical inhibitors, PD173074
and Su45402. As shown in Fig. 4b–e, both inhibitors sig-
nificantly decreased the level of phosphorylation of H2AX
in response to irradiation. We also confirmed the effect of
both inhibitors using alternative controls, including
GAPDH (Fig. 4c) and histones (Fig. 4d). The ATM in-
hibitor was also used as a control and was the most efficient
for decreasing H2AX phosphorylation, though it was not
completely abolished (Fig. 4d). As Su5402 was the most
efficient, we confirmed its ability to inhibit H2AX phos-
phorylation at 1, 3, and 6 h after irradiation and also
observed that it does not affect the basal level of H2AX
phosphorylation in the absence of irradiation (Fig. 4e).
Interestingly, the fact that most inhibitors, either siRNA or
chemical inhibitors (Figs. 3, 4b–e), were unable to com-
pletely abolish the cH2AX signal indirectly confirms that
many kinases participate in H2AX phosphorylation in re-
sponse to irradiation. Because of its membrane integration,
the effect of the FGF receptor on H2AX phosphorylation
was most likely indirect but could ultimately lead to in-
creased phosphorylation of H2AX after irradiation.
FGFR4-related phosphorylation of H2AX is
independent of ATM
To evaluate the role of ATM in H2AX phosphorylation in
response to FGF signaling, we overexpressed FGFR4 while
knocking down ATM in HaCaT cells and monitored the
phosphorylation of H2AX and the formation of cH2AX
foci (Fig. 5). We observed accumulation of cH2AX in
FGFR4-overexpressing cells in response to irradiation.
Interestingly, FGFR4 overexpression led to an increase in
cH2AX even in the absence of irradiation (Fig. 5). Phos-
phorylation of H2AX was reduced after ATM silencing in
control-plasmid transfected cells but not in FGFR4-over-
expressing cells. This result demonstrated that FGFR4
participates in the phosphorylation of H2AX via ki-
nase(s) other than ATM. Inhibition of ATM by siRNA
(Fig. 5) or specific chemicals (Fig. S4) did not completely
abolish the phosphorylation of H2AX (Fig. 5b), and two
peaks were clearly observed in the density curves (Fig. S4).
Again, these results confirmed that ATM is not the only
kinase able to phosphorylate H2AX and that downstream
of FGF signaling, other kinases phosphorylate H2AX in the
keratinocyte nucleus.
JNK1 phosphorylates H2AX downstream of FGF
signaling
Two candidate kinases, ERK1/2 and JNK1, which are
shuttled to the nucleus upon activation of FGFR4, could
potentially catalyze the phosphorylation of H2AX. To
confirm their involvement in H2AX phosphorylation and to
eliminate potential off-target effects, we used the chemical
inhibitors FR180204 and SP600125 to specifically inhibit
ERK1/2 and JNK1, respectively. Analysis of H2AX
phosphorylation after irradiation in the presence of each
inhibitor showed that JNK1 inhibition significantly reduced
H2AX phosphorylation (Fig. 6b), whereas the ERK in-
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Fig. 5 The role of FGFR4 in H2AX phosphorylation is independent
of ATM. a HaCaT cells were transfected with pCMV6-XL5/Mock
(control vector, p-CTL) or b pCMV6-XL5/FGFR4 (FGFR4 expres-
sion vector, p-FGFR4), along with control siRNA or ATM-targeted
siRNA. The cells were then irradiated at 2 Gy. The protein extracts
were analyzed by Western blotting using anti-cH2AX, anti-ATM, or
anti-FGFR4 antibodies. Actin expression was used as a control. Two
independent biological replicates were performed for this experiment
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confirmed by Western blotting (Fig. 6c) and demonstrated
that JNK1 was a potential candidate for H2AX phospho-
rylation downstream of FGF signaling.
Finally, we analyzed the time-course phosphorylation of
H2AX and JNK1 in response to DNA damage. As
demonstrated in Fig. 7a, Western blots of proteins ex-
tracted at different times after irradiation show that JNK1
kinase was phosphorylated as soon as 30 min after irra-
diation, concomitantly with H2AX. To further explore
whether JNK1 was directly involved in H2AX phospho-
rylation, we immunoprecipitated JNK1 using GST-c-Jun
agarose beads and analyzed the co-immunoprecipitated
proteins (Fig. 7b). We confirmed that JNK1 was phos-
phorylated as soon as 30 min after irradiation and showed
that H2AX and cH2AX were co-immunoprecipitated with
JNK1 and that their levels increased when JNK1 phos-
phorylation increased (Fig. 7b). These results suggest that
in response to ionizing radiation, JNK1 could directly in-
teract with and phosphorylate H2AX in the cell
downstream of FGF signaling.
Discussion
Phosphorylation of H2AX at DSBs allows for its par-
ticipation in the repair of DSBs by cellular machinery. To
date, three different kinases, ATM, ATR, and DNA-PK,
have been reported to be the catalysts of H2AX phospho-
rylation in response to genotoxic threats [19, 20]. The
kinome-targeted RNAi-based functional screen we per-
formed demonstrates that approximately 40 kinases
participate, directly or indirectly, in H2AX phosphoryla-
tion in response to irradiation. Several reasons may explain
why our characterization results in such a large number of
kinases. Classical approaches are unlikely to permit a
comprehensive characterization of signaling networks, as
they rely mostly on the analysis of specific kinases. The
analysis of DNA-repair pathways relies mainly on well-
characterized canonical components (e.g., ATM, ATR, and
DNA-PK). Performing exhaustive and unbiased screening
using non-canonical molecules, as in this study, measures
signaling outputs at different points within the network and
enables the discovery of new molecular targets. Further-
more, because H2AX phosphorylation was monitored at
the single-cell level, we were able to analyze the distri-
bution of the signal rather than its average, which
facilitates the characterization of subtle effects of kinases.
ATM is a serine/threonine protein kinase that is re-
cruited and activated by DNA double-strand breaks. It is
key molecule in DNA repair through the phosphorylation
of several targets, including p53, NBS1, and H2AX [36–
38]. ATM is also the main kinase responsible for the
phosphorylation of H2AX in response to ionizing radiation
[39], and in our screen, no siRNA was more efficient than
the ATM-targeting siRNA at decreasing H2AX phospho-
rylation. The ATM gene ranked third in terms of mutation
frequency in a recent analysis of 518 protein kinases in 210
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Fig. 6 Impact of the inhibition of either ERK or JNK on H2AX
phosphorylation. a HaCaT cells were irradiated at 2 Gy with or
without an ERK-specific inhibitor and then co-stained with DAPI and
anti-cH2AX fluorescent antibodies. The cH2AX-specific signal was
quantified at the single-cell level. b Similar to A with the JNK-
specific inhibitor. c cH2AX content was also analyzed by Western
blotting with or without inhibitors and with or without irradiation.
Two independent biological replicates were performed for c
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compensate for ATM loss of function. However, several
kinome-targeted functional screens in various organisms
have shown the implication of tens of kinases in a given
phenotype. Ninety kinases are involved in JAK/STAT
signaling [25], and 331 RTK/ERK pathway regulators were
found in Drosophila cells [26]. Seventy-three kinases were
identified as survival kinases in HeLa cells [27]. Fifty-nine
kinases were positive regulators of neurite outgrowth in
human cells, and 66 inhibited neurite outgrowth [40]. Even
more striking, the depletion of 159 signaling genes, nearly
20 % of the genes assayed, induced strong and varied
perturbations in Golgi morphology [28]. Our results and
those of others support the emerging view that there are not
a specific number of regulators in a signaling network. The
definition of the number of regulators is based instead on
arbitrary thresholds [26, 41, 42]. Furthermore, our results
and those of others argue against the idea that signaling
pathways are limited to a few canonical components and
show that large regulatory networks have a graded effect
on signaling output [43], even though some key kinases can
still have a major effect relative to others.
Paulsen et al. [44] conducted a genome-wide screen to
identify all human genes that upon siRNA-mediated in-
hibition resulted in increased phosphorylation of H2AX.
They identified hundreds of genes whose knockdown re-
sulted in more cH2AX and revealed that the preservation
of genome stability is mediated by a large network of
genes. Our objective was complementary to this previous
study in that we looked for kinases whose knockdown
resulted in less cH2AX. Surprisingly, our screen revealed
that membrane-associated kinases such as JAK1, or even
membrane-bound kinases such as FGFR4, were involved
in H2AX phosphorylation. The implication of membrane-
associated proteins in the phosphorylation of H2AX has
previously been reported but not in response to radiation.
Indeed, it was demonstrated that commitment of the
GABA receptor reduced stem cell proliferation via phos-
phorylation of H2AX and that ATM and DNA-PK
catalyze this reaction [45]. However, looking carefully at
this result, it could be observed that the inhibition of
H2AX phosphorylation by an ATM-DNA-PK-specific in-
hibitor was not completely efficient, suggesting that other
kinases were involved in the reaction, which is in agree-
ment with the data presented here. Our experiments
demonstrated that FGFR4 phosphorylates H2AX inde-
pendently of ATM and that FGFR4 triggers a signaling
cascade that eventually activates JNK1. Immunopre-
cipitation of H2AX along with JNK1 clearly indicates that
H2AX is a substrate of this MAP kinase. This result is in
agreement with the report that JNK1 phosphorylates
H2AX in response to UV radiation [46]. This phospho-
rylation resulted in apoptosis.
In the early 1990s, the Fuks group reported the effect of
FGF in the repair of radiation damage [1, 2]. Since then,
numerous studies have demonstrated the radioprotective
effect of several fibroblast growth factors, which may even
have potential for clinical use as radioprotectors [3–7, 47,
48]. However, the underlying molecular mechanisms have
never been completely characterized. Our results clearly
link FGFR-dependent signaling to H2AX phosphorylation
in response to radiation. Together, these results suggest that
the presence of FGF will increase the phosphorylation of
H2AX, leading in turn to more efficient DNA repair. The
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Fig. 7 H2AX and JNK1 interaction assay. a The kinetics of H2AX
and JNK1 phosphorylation in HaCaT cell 30 min, 1, 2, or 4 h after
irradiation was directly monitored by Western blotting for cH2AX,
H2AX, JNK1, and pJNK1, with b-actin used as a charge control.
b The same protein extracts were incubated with GST-C-Jun beads to
immunoprecipitate JNK1 using a SAPK/JNK Kinase Assay Kit and to
monitor co-immunoprecipitated proteins. Immunoprecipitated
proteins were separated by SDS-PAGE 30 min, 1, 2, or 4 h after
irradiation. The presence of cH2AX, H2AX, JNK1, and pJNK1 was
evaluated by Western blotting, and C-Jun was used as a charge
control. H2AX and cH2AX were co-immunoprecipitated with JNK as
soon as 30 min and up to 2 h after irradiation. Two independent
biological replicates were performed
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irradiation, which in turn can explain the protective effect
of FGF [17–21, 42, 44].
In contrast, deregulation of FGF signaling was shown to
be associated with carcinogenesis. Mutations in FGFR4
have been reported in lung cancer and breast cancer [49],
and FGFR4 polymorphisms have been observed in squa-
mous cell carcinoma [50] and breast cancer [51]. Finally,
the FGFR4 Gly388Arg polymorphism has been shown to
be a potential marker for prostate cancer development and
progression [52, 53]. Interestingly, it seems that FGFR4
triggers the formation of cH2AX even in the absence of
irradiation (Fig. 5b), which is in agreement with the
oncogene-induced DNA damage model [54].
Although the mechanisms responsible for the different
responses of cells to mutant FGFRs remain unclear, it
has been postulated to be related to their ability to en-
gage signaling pathways that can both promote and
suppress proliferation, as well as by triggering negative
feedback mechanisms [55]. As a consequence, several
FGF signaling inhibitors were recently developed as new
cancer therapeutic agents [56]. However, such inhibitors
may trigger adverse reactions to radiation therapy and
would have to be used with caution. Although H2AX
and the PI3K-related kinases that phosphorylate H2AX
have both been proposed as potential therapeutic targets
[57–60], our results suggest the value of a multi-
therapeutic approach that targets several kinases rather
than only one.
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